New Delhi: Having yielded encouraging results in the initial phases of its trial, one of the three COVID-19 vaccine candidates would enter the third phase of the pre-clinical human trial by Wednesday, informed the Ministry of Health and Family Welfare on Tuesday.
Head of the national task force on COVID-19, Dr. V.K. Paul informed about the development during a weekly press briefing, said media reports.
While not sharing the names of the other two vaccines, Paul added that they are currently in phase-I or II of their pre-clinical trials.
India has three vaccine candidates for COVID-19 – ChAdOx1, developed by Oxford University and manufactured jointly by the Serum Institute of India (SII), Pune and AstraZeneca, Bharat Biotech’s Covaxin, jointly developed with the Indian Council of Medical Research and the third is ZycovD by Zydus Cadila.
Kolkata: The Railway Protection Force (RPF) of Eastern Railway (ER) claimed to have seized foreign… Read More
Bhubaneswar: Newly-appointed Odisha Congress president Bhakta Charan Das underwent a successful surgery for an injury… Read More
Bhubaneswar: Thunderstorm activity with lightning, gusty surface wind and hail may continue in Odisha till… Read More
Bhadrak: Police busted a sex racket operating from a hotel in Odisha's Bhadrak district late… Read More
New Delhi: Delhi Metro Rail Corporation (DMRC) claimed to have scaled the highest point till… Read More
Bhubaneswar: The Odisha Vigilance sleuths on Sunday apprehended Assistant Agriculture Officer lock Technology Manager and… Read More
This website uses cookies.
